Sibionics Raises RMB 500 Million in Series D Financing Round
Shenzhen-based chronic disease device maker Sibionics has reportedly raised close to RMB 500 million (USD...
Fineline Cube
Waker Bioscience Raises Angel Funding for ISA Technology Upgrades
Waker Bioscience, an integration site analysis (ISA) specialist based in Shanghai, has reportedly raised “tens...
InnoCare Receives CDE Approval for Phase II Trial of Orelabrutinib Combination
China-based biopharma InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving approval from China’s Center...
Ronovo Surgical Raises Pre-Series B Funding for Surgical Robot Development
Ronovo Surgical, a minimally invasive surgery device maker based in Shanghai, has reportedly raised “tens...
PingAn Good Doctor Partners to Establish Lifestyle Medicine
China-based PingAn Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor,...
JW Therapeutics Collaborates with Juno for DLL3 CAR-T Therapy Development
China-based JW Therapeutics Co., Ltd (HKG: 2126) has issued a stock exchange announcement revealing a...
Mabwell Bioscience Licenses Biosimilars to Russian Firm Binnopharm
China-based Mabwell Bioscience (SHA: 688062) has announced the establishment of a licensing agreement with the...
Sirnaomics’ Lead Candidate STP707 Shows Promising Phase I Data
Sino-US small interfering RNA (siRNA) specialist Sirnaomics (HKG: 2257) has revealed that its lead pipeline...
Kira Pharmaceuticals Gains NMPA and TGA Approvals for KP104 Phase II Study
Sino-US biotech Kira Pharmaceuticals has announced receiving approvals from China’s National Medical Products Administration (NMPA)...
TowardPi Raises RMB 300 Million in Series C Financing Round
China-based ophthalmology device maker TowardPi (Beijing) Medical Technology Ltd has reportedly raised close to RMB...
Aosaikang Receives FDA Approval for ASKG915 Clinical Trial
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced receiving clinical trial approval for its...
Pfizer Exercises Option for Sisunatovir Rights with LianBio
US major Pfizer Inc. (NYSE: PFE) has agreed with China-based LianBio (OTCMKTS: LIANY) to exercise...
Fosun Pharma Registers Comirnaty Vaccines in Hong Kong
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) has announced that Comirnaty (BNT162b2) and Comirnaty bivalent...
XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with the Experimental Drug...
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
Hong Kong-based Prenetics Global Ltd (NASDAQ: PRE) has announced the acquisition of a majority stake...
CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has announced that the Medicines and Healthcare products Regulatory Agency...
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
China-based Ascletis Pharma Inc. (HKG: 1672) has announced receiving the Notice of Issuance from the...
HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
Hutchison China Meditech (HutchMed; HKG: 0013, NASDAQ: HCM) has announced the initiation of a rolling...
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary Shandong Boan Biotechnology Co., Ltd has officially...